Letter/Communication
Oral Iptacopan Monotherapy: A New Frontier for Paroxysmal Nocturnal Hemoglobinuria
NEJM journal watch. Oncology & hematology
03/25/2024
Abstract
Iptacopan, a first-in-class oral factor B inhibitor, could provide an additional therapeutic option for treatment of PNH.
Details
- Title: Subtitle
- Oral Iptacopan Monotherapy: A New Frontier for Paroxysmal Nocturnal Hemoglobinuria
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 03/25/2024
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984577113102771
Metrics
2 Record Views